Sponsors (2)
The bill strengthens CPSC oversight and lab monitoring to reduce children’s exposure to toxicants and speed enforcement, but it imposes compliance costs on manufacturers and testing labs and creates short-term administrative strain and potential confusion during rapid implementation.
Children and their families will face lower risk of exposure to lead, phthalates, and other toxicants because the CPSC will have stronger oversight of children’s products and testing.
Consumers and caregivers will get more timely enforcement, recalls, and compliance monitoring due to a required e-filing oversight plan that improves tracking of violations.
Testing lab quality will be better identified and managed because the CPSC will use violations data to risk-assess independent and government testing laboratories, improving product safety.
Manufacturers and independent testing labs will face new compliance, reporting, and more frequent review costs, which could raise business expenses and potentially consumer prices.
The CPSC will incur administrative and resource burdens to meet a 180‑day implementation deadline, potentially diverting staff and attention from other safety work.
Rushed implementation to meet deadlines could produce incomplete processes and require later revisions, causing short-term confusion for families, state officials, and other stakeholders.
Based on analysis of 2 sections of legislative text.
Requires the CPSC to implement GAO recommendations to strengthen oversight and monitoring of lead, phthalates, and other toxic substances in children's products and report to Congress.
Official title: Direct the Consumer Product Safety Commission to implement children's product safety recommendations of the Government Accountability Office.
Introduced June 24, 2026 by Thomas Jonathan Ossoff · Last progress June 24, 2026
Requires the Consumer Product Safety Commission to implement GAO recommendations on strengthening oversight of toxic substances in children’s products. Agencies must set up e-filing oversight, use lab violation data to assess risk, review and document lead requirements on a five-year cycle, and create monitoring for phthalates and other toxic chemicals, then report actions to relevant congressional committees.